Femasys Inc. (FEMY) - Form 8-K Summary
Business Context and Reporting Period
This report covers a Special Meeting of Stockholders held on April 29, 2026. Femasys Inc., a Delaware corporation listed on the Nasdaq Capital Market, reported the final voting results for two critical proposals regarding its capital structure and compliance with Nasdaq listing rules.
Key Financial Metrics
The filing does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt levels, or liquidity ratios. The document focuses exclusively on corporate governance and voting outcomes.
Material Changes and Voting Results
Stockholders representing approximately 39.91% of eligible shares (24,102,261 shares) participated in the meeting. Both proposals were approved:
- Proposal One (Reverse Stock Split): Stockholders approved an amendment to the Certificate of Incorporation to authorize a reverse stock split at a ratio between 1-for-2 and 1-for-25. The Board of Directors may determine the specific ratio at any time prior to May 1, 2027.
- Votes For: 18,914,440
- Votes Against: 5,187,820
- Abstentions: 1
- Proposal Two (Issuance of Shares): Stockholders approved the issuance of shares from convertible notes and warrants (including November Warrants and Series D-1 Warrants) in excess of 19.99% of outstanding shares. This is required to comply with Nasdaq Listing Rules 5635(c) and 5635(d) regarding anti-dilution provisions that result in conversion or exercise prices below the Nasdaq Minimum Price.
- Votes For: 7,483,951
- Votes Against: 1,693,085
- Abstentions: 0
- Broker Non-Votes: 14,925,225
Due to the approval of both proposals, the Adjournment Proposal was not presented.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the context of the voting proposals. The primary implication is the potential for significant dilution or share count reduction depending on the Board's execution of the reverse split and the conversion of debt instruments.
Investor Verification Checklist
- Verify the specific reverse split ratio selected by the Board of Directors before May 1, 2027.
- Monitor the Nasdaq Minimum Price to determine if the anti-dilution provisions on the Notes and Warrants will trigger share issuances.
- Review the terms of the Securities Purchase Agreement (dated November 3, 2025) and the Omnibus Amendment (dated March 19, 2026) to understand the potential dilution impact.
- Check subsequent filings for the effective date of the reverse split and any resulting changes to the share count.